Ad
related to: covid-19 vaccine update pfizer
Search results
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 6 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
Motley Fool via Yahoo Finance· 4 days agoThe Stock Advisor service has more than quadrupled the return...Motley Fool has positions in and...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoThe Stock Advisor service has more than quadrupled the return...any of the stocks mentioned. Keith Speights has positions in Bristol Myers Squibb and ...
COVID summer wave grows, with new variant LB.1 on the rise
WLTX-TV Columbia· 4 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
Motley Fool via Yahoo Finance· 13 hours agoMore than a half-dozen of Wall Street's most-successful billionaire investors dumped shares of...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 5 days agoThe company says it will have the results of that study soon. Meanwhile, Pfizer began testing its...
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 3 days agoThe Stock Advisor service has more than quadrupled the return...any of the stocks mentioned. Keith Speights has positions in Bristol Myers Squibb and Pfizer. Prosper Junior ...
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks
The Motley Fool via AOL· 13 hours agoMore than a half-dozen of Wall Street's most-successful billionaire investors dumped shares of...
Novavax executive Dubovsky sells over $200k in company stock By Investing.com
Investing.com· 5 days agoNovavax Inc. (NASDAQ:NVAX) has reported recent stock transactions by President of Research and...
Novavax director James Young sells shares worth over $100k By Investing.com
Investing.com· 4 days agoJames F. Young, a director at Novavax Inc. (NASDAQ:NVAX), has sold a total of 7,500 shares of the...
